UVA earns accreditation for its use of stem cells and bone marrow to treat patients with blood cancers, including leukemia, lymphoma and multiple myeloma
Tag: thomas loughran
With a recent $10 million NIH program project grant, UVA top minds are working to reveal the potential of nanotechnology to treat cancer. Get a breakdown of how these tiny particles enhance drug delivery and learn how UVA is putting them to use.
The Bone Marrow and Stem Cell Transplant Program at UVA Cancer Center has been designated as a National Marrow Donor Program (NMDP)/Be the Match® transplant center.